|
| Exchange Disseminated Time 29/08/2016 17:51:53 | Ortin Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 29, 2016, has transacted the following;
1. In principle approval to demerge its intermediary business and in this regard the Board has formed a Restructuring Committee to detail the nuances of the demerger structure, including valuation, share entitlement ratio and other incidental matters and to present the same before the next meeting of the Board.
2. Constitution of Restructuring Committee comprising of Mr. S. Murali Krishna Murthy, Managing Director and Mr. G. Venkata Ramana, Joint Managing Director of the Company. |
|
|